Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ConvaTec ( (GB:CTEC) ) has shared an announcement.
ConvaTec Group PLC has executed a share buyback transaction, purchasing 1,380,335 ordinary shares at a volume-weighted average price of 231.74 pence per share. This move is part of a larger $300 million share buyback program announced in August 2025, which aims to optimize the company’s capital structure and potentially enhance shareholder value. The purchased shares will be held in treasury, adjusting the total voting rights to 2,027,613,359 shares, excluding treasury shares.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £260.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.
ConvaTec’s overall stock score is driven primarily by its strong financial performance, which is offset by a cautious technical outlook and a relatively high valuation. The company’s robust financial health and effective cash flow management are significant strengths. However, the lack of positive technical indicators and a high P/E ratio suggest potential risks in the current market environment.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC operates in the medical products and technologies industry, focusing on wound care, ostomy care, continence and critical care, and infusion care. The company serves healthcare providers and patients globally, aiming to improve the lives of people with chronic conditions.
Average Trading Volume: 7,722,346
Technical Sentiment Signal: Hold
Current Market Cap: £4.7B
For an in-depth examination of CTEC stock, go to TipRanks’ Overview page.